Where The Moonshot Meets The Road: Could Biden's Plan Boost Cures Bill?
Executive Summary
Maybe, but Sen. Alexander lists 21st Century Cures-like legislation below education issues on his 2016 priority list.
You may also be interested in...
Biden’s Cancer Initiative May Intensify Industry, Government Collaboration
Drug companies and NIH embrace Vice President’s call for moonshot to cure cancer; Amgen and Celgene join separate coalition to test 60 molecules in combination Phase II studies.
CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings
FDA officials have said hiring could be slowed if an inflationary pay increase is not included in the agency budget, but CDER and CBER continue to add staff at a steady pace.
Parallel Scientific Advice: Is The EMA User Fee Impacting Interest?
EMA charges participants to receive scientific advice through the fledgling program, unlike the US FDA, which may not fit the budgets of some complex generic sponsors. At the same time, sponsors also may simply not be aware the program exists yet.